dwb2023 commited on
Commit
a58039d
1 Parent(s): aaaff0a

update dataset card

Browse files
Files changed (1) hide show
  1. README.md +48 -91
README.md CHANGED
@@ -44,115 +44,86 @@ tags:
44
  - chemistry
45
  - medical
46
  ---
47
- # Dataset Card for Dataset Name
48
-
49
- <!-- Provide a quick summary of the dataset. -->
50
-
51
- This dataset card aims to be a base template for new datasets. It has been generated using [this raw template](https://github.com/huggingface/huggingface_hub/blob/main/src/huggingface_hub/templates/datasetcard_template.md?plain=1).
52
 
53
  ## Dataset Details
54
 
55
  ### Dataset Description
56
 
57
- <!-- Provide a longer summary of what this dataset is. -->
58
-
59
-
60
-
61
- - **Curated by:** [More Information Needed]
62
- - **Funded by [optional]:** [More Information Needed]
63
- - **Shared by [optional]:** [More Information Needed]
64
- - **Language(s) (NLP):** [More Information Needed]
65
- - **License:** [More Information Needed]
66
-
67
- ### Dataset Sources [optional]
68
-
69
- <!-- Provide the basic links for the dataset. -->
70
-
71
- - **Repository:** [More Information Needed]
72
- - **Paper [optional]:** [More Information Needed]
73
- - **Demo [optional]:** [More Information Needed]
74
-
75
- ## Uses
76
-
77
- <!-- Address questions around how the dataset is intended to be used. -->
78
-
79
- ### Direct Use
80
-
81
- <!-- This section describes suitable use cases for the dataset. -->
82
-
83
- [More Information Needed]
84
-
85
- ### Out-of-Scope Use
86
-
87
- <!-- This section addresses misuse, malicious use, and uses that the dataset will not work well for. -->
88
-
89
- [More Information Needed]
90
 
91
- ## Dataset Structure
 
 
 
 
92
 
93
- <!-- This section provides a description of the dataset fields, and additional information about the dataset structure such as criteria used to create the splits, relationships between data points, etc. -->
94
 
95
- [More Information Needed]
 
 
96
 
97
- ## Dataset Creation
98
 
99
- ### Curation Rationale
100
 
101
- <!-- Motivation for the creation of this dataset. -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
102
 
103
- [More Information Needed]
104
 
105
- ### Source Data
106
 
107
- <!-- This section describes the source data (e.g. news text and headlines, social media posts, translated sentences, ...). -->
108
 
109
  #### Data Collection and Processing
110
 
111
- <!-- This section describes the data collection and processing process such as data selection criteria, filtering and normalization methods, tools and libraries used, etc. -->
112
 
113
- [More Information Needed]
 
 
 
114
 
115
  #### Who are the source data producers?
116
 
117
- <!-- This section describes the people or systems who originally created the data. It should also include self-reported demographic or identity information for the source data creators if this information is available. -->
118
 
119
- [More Information Needed]
120
 
121
- ### Annotations [optional]
122
 
123
- <!-- If the dataset contains annotations which are not part of the initial data collection, use this section to describe them. -->
124
-
125
- #### Annotation process
126
-
127
- <!-- This section describes the annotation process such as annotation tools used in the process, the amount of data annotated, annotation guidelines provided to the annotators, interannotator statistics, annotation validation, etc. -->
128
-
129
- [More Information Needed]
130
 
131
  #### Who are the annotators?
132
 
133
- <!-- This section describes the people or systems who created the annotations. -->
134
-
135
- [More Information Needed]
136
-
137
- #### Personal and Sensitive Information
138
-
139
- <!-- State whether the dataset contains data that might be considered personal, sensitive, or private (e.g., data that reveals addresses, uniquely identifiable names or aliases, racial or ethnic origins, sexual orientations, religious beliefs, political opinions, financial or health data, etc.). If efforts were made to anonymize the data, describe the anonymization process. -->
140
-
141
- [More Information Needed]
142
-
143
- ## Bias, Risks, and Limitations
144
 
145
- <!-- This section is meant to convey both technical and sociotechnical limitations. -->
146
 
147
- [More Information Needed]
148
 
149
  ### Recommendations
150
 
151
- <!-- This section is meant to convey recommendations with respect to the bias, risk, and technical limitations. -->
152
 
153
- Users should be made aware of the risks, biases and limitations of the dataset. More information needed for further recommendations.
154
-
155
- ## Citation [optional]
156
 
157
  **BibTeX:**
158
 
@@ -173,20 +144,6 @@ Users should be made aware of the risks, biases and limitations of the dataset.
173
  }
174
  ```
175
 
176
- ## Glossary [optional]
177
-
178
- <!-- If relevant, include terms and calculations in this section that can help readers understand the dataset or dataset card. -->
179
-
180
- [More Information Needed]
181
-
182
- ## More Information [optional]
183
-
184
- [More Information Needed]
185
-
186
- ## Dataset Card Authors [optional]
187
-
188
- [More Information Needed]
189
-
190
  ## Dataset Card Contact
191
 
192
- [More Information Needed]
 
44
  - chemistry
45
  - medical
46
  ---
47
+ # Dataset Card for PMC_35559673_table_s datasets
 
 
 
 
48
 
49
  ## Dataset Details
50
 
51
  ### Dataset Description
52
 
53
+ This dataset contains the results of genome-wide CRISPR screens using isogenic knockout cells to uncover vulnerabilities in tumor suppressor-deficient cancer cells. The data were originally published by Feng et al., *Sci. Adv.* 8, eabm6638 (2022), and are available via PubMed Central (PMC). The supplementary tables included in this dataset provide detailed data on raw counts, essentiality calls, Bayes factors, and synthetic lethality (SL) hits. The dataset supports research into genetic dependencies and potential therapeutic targets.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54
 
55
+ - **Curated by**: Feng et al., Sci. Adv. 8, eabm6638 (2022)
56
+ - **Funded by**: Likely supported by institutions affiliated with the authors.
57
+ - **Shared by**: Feng et al.
58
+ - **Language(s)**: Not applicable (biomedical dataset).
59
+ - **License**: CC BY 4.0
60
 
61
+ ### Dataset Sources
62
 
63
+ - **Repository**: [PubMed Central](https://pubmed.ncbi.nlm.nih.gov/35559673/)
64
+ - **Paper**: [Sci. Adv. 8, eabm6638 (2022)](https://doi.org/10.1126/sciadv.abm6638)
65
+ - **Supplementary Materials**: [Tables S1-S7](https://www.science.org/doi/suppl/10.1126/sciadv.abm6638/suppl_file/sciadv.abm6638_tables_s1_to_s7.zip)
66
 
67
+ ### Dataset Structure
68
 
69
+ This dataset consists of seven tables (S1-S7), each representing a different aspect of the CRISPR screen results:
70
 
71
+ 1. **Table S1**: Raw counts for all CRISPR screens in this study.
72
+ - **File Mapping**: `sciadv.abm6638_table_s1.xlsx`
73
+
74
+ 2. **Table S2**: Binary essentiality calls matrix.
75
+ - **File Mapping**: `sciadv.abm6638_table_s2.xlsx`
76
+
77
+ 3. **Table S3**: Quantile-normalized Bayes factor (QBF) matrix.
78
+ - **File Mapping**: `sciadv.abm6638_table_s3.xlsx`
79
+
80
+ 4. **Table S5**: Total SL hits identified for each TSG KO screen.
81
+ - **File Mapping**: `sciadv.abm6638_table_s5.xlsx`
82
+
83
+ 5. **Table S6**: Shared SL hits across each TSG KO screen.
84
+ - **File Mapping**: `sciadv.abm6638_table_s6.xlsx`
85
+
86
+ 6. **Table S7**: Unique SL hits for each TSG KO screen.
87
+ - **File Mapping**: `sciadv.abm6638_table_s7.xlsx`
88
 
89
+ ### Dataset Creation
90
 
91
+ #### Curation Rationale
92
 
93
+ This dataset was curated to facilitate research into the vulnerabilities of cancer cells deficient in tumor suppressor genes. The binary essentiality calls, synthetic lethality (SL) hits, and other data allow researchers to explore genetic interactions that could serve as potential therapeutic targets. The methodology behind the CRISPR screens and SL hit identification was detailed by Feng et al. in their 2022 study.
94
 
95
  #### Data Collection and Processing
96
 
97
+ Data were collected from genome-wide CRISPR screens performed on isogenic knockout cells. The data were processed to produce raw counts, binary essentiality calls, and genetic interaction matrices, including shared and unique synthetic lethal hits.
98
 
99
+ Relevant references describing the data processing and methods can be found in the following sources:
100
+ - *Evaluation and design of genome-wide CRISPR/SpCas9 knockout screens* (PMID: 28655737)
101
+ - *High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities* (PMID: 26627737)
102
+ - *Identifying chemogenetic interactions from CRISPR screens with drugZ* (PMID: 31439014)
103
 
104
  #### Who are the source data producers?
105
 
106
+ The data were produced by Feng et al., as part of their research published in *Science Advances*. The researchers were affiliated with academic institutions engaged in cancer genomics and CRISPR screening methodologies.
107
 
108
+ ### Annotations
109
 
110
+ #### Annotation Process
111
 
112
+ Annotations were primarily focused on identifying shared and unique synthetic lethality hits across tumor suppressor knockout screens. Automated processing tools like CRISPR analysis pipelines were employed for initial hit identification, followed by manual validation based on genetic interactions.
 
 
 
 
 
 
113
 
114
  #### Who are the annotators?
115
 
116
+ The original authors, including experts in CRISPR screening and cancer genomics, performed the annotations. No third-party annotations were added.
 
 
 
 
 
 
 
 
 
 
117
 
118
+ ### Bias, Risks, and Limitations
119
 
120
+ The dataset is limited to specific cancer cell lines and tumor suppressor gene knockouts. As a result, the findings may not be generalizable across all cancer types. Users should exercise caution when interpreting results outside the experimental context.
121
 
122
  ### Recommendations
123
 
124
+ Users should consult the references provided to better understand the experimental design and limitations. The dataset is best suited for research applications in cancer genomics, genetic interactions, and therapeutic target discovery.
125
 
126
+ ## Citation
 
 
127
 
128
  **BibTeX:**
129
 
 
144
  }
145
  ```
146
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
147
  ## Dataset Card Contact
148
 
149
+ dwb2023